Related by context. Frequent words. (Click for all words.) 63 Rhone Poulenc Rorer 62 Price Waterhouse LLP 61 Dr. Sidransky 61 Immunex Corporation 61 Boehringer Mannheim 60 PETAQUILLA MINERALS LTD 60 Kevin Buchi 60 Sachiko Kuno Ph.D. 59 Receptos 59 Morgan J. Poliquin 59 Nominating Corporate Governance 59 Owlstone Nanotech Inc. 59 Hoechst Marion Roussel 58 ICON plc 58 Agennix AG 58 Faheem Hasnain 58 Compensation Committees 58 Marakon Associates 58 Valera Pharmaceuticals 58 FermaVir 58 Connetics Corporation 57 Corporate Governance Committee 57 Files Shelf Registration Statement 57 XTLbio 57 Dr. Manfred Bischoff 57 NeuroMedix 57 Juergen Engel Ph.D. 57 AVEO Pharmaceuticals 57 MINRAD 57 A. Pontius 57 Board ofDirectors 57 Audit Committees 57 Aerovance 57 NormOxys 57 CARDERO RESOURCE CORP. 57 http:/www.pharmacopeia.com 56 Cerus Corporation 56 Nominating Committees 56 visit www.easylink.com 56 ICN Pharmaceuticals 56 GlaxoWellcome 56 QuatRx 56 Zosano 56 Oleg Khaykin 56 Sinks Lower 56 Genaera Corporation 56 Corporate Governance Committees 56 Sprott Consulting 56 own Z# 3DVisor 56 Corporate Controller 56 CFO Exercises Options 56 OncoGenex Pharmaceuticals 56 NYSE BVF TSX 56 Prism Pharmaceuticals 55 BioLife Solutions 55 Oxxon 55 Energy LLC DPLE 55 Shareholders Approve Acquisition 55 Daniel Junius 55 FluoroPharma 55 Q3 Adj 55 Welcomes Analyst Initiation 55 Condella 55 Jeffrey H. Buchalter 55 Announce Merger Agreement 55 Joel F. Gemunder 55 www.vivus.com 55 inTEST Corporation 55 Preclinical Development 55 Inc Therapeutic Competitors 55 Chief ExecutiveOfficer 55 Governance Committees 55 AGTC 55 Greisch 55 Principal Executive Officer 55 Novastar Resources 55 Tunnell LLP 55 Syntonix 55 PRAECIS PHARMACEUTICALS INCORPORATED 55 M.Sc. P.Eng 55 Director Shareholding 55 Alberto Cribiore 55 Warren Kanders 55 LGL Group 55 Symyx Technologies 55 Paul F. Matysek 55 Therapeutic Competitors Report 55 Discusses Q3 55 Dynogen 55 Auriga Laboratories 55 Ueno founded 55 please visit http:/www.supergen.com 55 Earnings Postmortem 55 Alantos 55 Restate Financial 55 Agios Pharmaceuticals 55 Transave 55 ACLARA 55 Attracting Bullish Investors 55 Xphase 54 Bio Quant